학술논문
甲狀線 分化癌의 방사성 요드-131 治療에 대한 臨庶的 考察
이용수 0
- 영문명
- A Clinical Review of Radioactive Iodine-131 Therapy in Differentiated Thyroid Carcinoma
- 발행기관
- 대한두경부종양학회
- 저자명
- 박윤규(Yoon Kyu Park) 이대영(Dae Young Lee) 전성은(Seong Eun Chon) 오성수(Sung Soo Oh) 정을삼(Eul Sam Chung)
- 간행물 정보
- 『대한두경부종양학회지』제12권 제1호, 32~42쪽, 전체 11쪽
- 주제분류
- 의약학 > 종양학
- 파일형태
- 발행일자
- 1996.06.30
4,120원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
This study was desinged to evaluate the effect of radioactive iodine-131 therapy in differentiated thyroid carcinoma treated at the Presbyterian Medical Center, Chonju during the 20-year period from 1975 to 1994. The authors reviewed 246 patients who received radioactive iodine-131. An analysis of the therapeutic response and survival rates of the 246 patients has been carried out.
The male to female ratio was 1 : 3.6.
The peak incidence was in the 4th and 6th decades.
The histologic findings in the 246 patients were papillary adenocarcinoma in 200 cases, follicular adenocarcinoma in 29 cases, mixed type in 14 cases, and others in 3 cases.
Combined treatment modalities of 246 patients consisted of sugery and radioiodine in 222 cases, surgery with radioiodine and external irradiation in 11 cases, and surgery with radioiodine, external irradiation and chemotherapy in 5 cases.
42 of the 246 cases showed recurrence and the commonest type of combined treatment for recurrent case was surgery followed by radioiodine-131.
The highest accumulated total dosage of radioiodine-131 was 480mCi in that case femoral metastasis was noticed. The most common locoregional metastatic site was ipsilateral cervical node, and neighbouring muscle, vessel, trachea, recurrent layngeal nerve, in order of frequency.
The determinate 10-year survival rate was 91.8% in the group receiving surgery followed by radioiodine-13l and 71.4% in patients receiving surgery, radioiodine-13l with XRT.
The determinate 10-year survival rate was better for patients under 40 years of age who received radioiodine as compared to patients over 40 year of age(85.7% vs. 33.3%).
The most usual primary therapeutic dosage in the group of cervical lesion was 90120mCi after surgery.
목차
Abstract
서론
대상 및 방법
관찰결과
고찰
결론
References
해당간행물 수록 논문
- 비인강암종의 구제치료
- 코의 Angiocentric Immunoproliferative Lesions(AILs)
- 유두상 갑상선암의 치료
- 부인두강 종물로 발현된 갑상선 유두상암종
- 병기 T1 성문암의 방사선치료
- 비인강암의 임상적 특성
- 비인강암의 수술적 치료
- 기능성 부갑상선 선종에 의한 원발성 부갑상선 기능항진증
- 하구순 편평상피암의 절제후 재건 치험례
- OK-432 경화요법으로 치유된 Plunging Ranula
- 비인강암의 방사선학적 진단
- 국소진행성 두경부암 환자에서 선행항암화학요법
- 전두동에서 발생한 편평세포암종 치험 1례
- 후두와 기관을 침범한 갑상선암의 치료
- 새성기형
- 甲狀線 分化癌의 방사성 요드-131 治療에 대한 臨庶的 考察
참고문헌
관련논문
의약학 > 종양학분야 BEST
- 방사선 치료에 내성이 유도된 두경부 편평세포암에 대한 종양살상 헤르페스 바이러스의 유전자 치료 효과
- 식도암에서 근치적 절제술 후 방사선치료의 역할
- 두경부암에서 면역회피 기전과 면역항암제 치료
의약학 > 종양학분야 NEW
- Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
- Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
- Hypofractionated radiation therapy for head and neck cancers in the era of intensity-modulated radiation therapy
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!